|
82
|
285
|
4r1yA |
Identification and optimization of pyridazinones as potent and selective c-met kinase inhibitor |
|
109
|
656
|
4qt8A |
Crystal structure of ron sema-psi-ipt1 extracellular domains in complex with msp beta-chain |
|
71
|
297
|
4riwB |
Crystal structure of an egfr/her3 kinase domain heterodimer |
|
86
|
308
|
4r6vA |
Crystal structure of fgf receptor (fgfr) 4 kinase harboring the v550l gate-keeper mutation in complex with fiin-3, an irreversible tyrosine kinase inhibitor capable of overcoming fgfr kinase gate-keeper mutations |
|
86
|
323
|
4r3pA |
Crystal structures of egfr in complex with mig6 |
|
33
|
191
|
4ra0C |
An engineered axl 'decoy receptor' effectively silences the gas6-axl signaling axis |
|
95
|
291
|
4r1vA |
Identification and optimization of pyridazinones as potent and selective c-met kinase inhibitors |
|
87
|
299
|
4qqjA |
Crystal structure of fgf receptor (fgfr) 4 kinase domain harboring the v550l gate-keeper mutation |
|
86
|
323
|
4r3rA |
Crystal structures of egfr in complex with mig6 |
|
90
|
291
|
4pmsA |
The structure of trka kinase bound to the inhibitor 4-naphthalen-1-yl-1-[(5-phenyl-1,2,4-oxadiazol-3-yl)methyl]-1h-pyrrolo[3,2-c]pyridine-2-carboxylic acid |
|
82
|
286
|
4pdoA |
Structure of ephrin type-a receptor 2 |
|
90
|
296
|
4p5qA |
Human epha3 kinase domain in complex with quinoxaline derivatives |
|
84
|
295
|
4p5zA |
Human epha3 kinase domain in complex with quinoxaline derivatives |
|
85
|
292
|
4p4cA |
Human epha3 kinase domain in complex with quinoxaline derivatives |
|
63
|
309
|
4q5jA |
Crystal structure of semet derivative bri1 in complex with bki1 |
|
138
|
606
|
4p59A |
Her3 extracellular domain in complex with fab fragment of mor09825 |
|
81
|
277
|
4p2kA |
Structure of ephrin type-a receptor 2 |
|
85
|
291
|
4pmtA |
The structure of trka kinase bound to the inhibitor n~4~-(4-morpholin-4-ylphenyl)-n~6~-(pyridin-3-ylmethyl)pyrido[3,2-d]pyrimidine-4,6-diamine |
|
74
|
261
|
4pbvA |
Crystal structure of chicken receptor protein tyrosine phosphatase sigma in complex with trkc |
|
78
|
281
|
4otwA |
Her3 pseudokinase domain bound to bosutinib |
|
32
|
197
|
4pgzA |
Structural basis of kit activation by oncogenic mutations in the extracellular region reveals a zipper-like mechanism for ligand-dependent or oncogenic receptor tyrosine kinase activation |
|
94
|
291
|
4pmmA |
The structure of trka kinase bound to the inhibitor n-(3-cyclopropyl-1-phenyl-1h-pyrazol-5-yl)-2-{4-[3-methoxy-4-(4-methyl-1h-imidazol-1-yl)phenyl]-1h-1,2,3-triazol-1-yl}acetamide |
|
65
|
273
|
4pbwA |
Crystal structure of chicken receptor protein tyrosine phosphatase sigma in complex with trkc |
|
71
|
306
|
4ogaE |
Insulin in complex with site 1 of the human insulin receptor |
|
87
|
302
|
4nkaA |
Crystal structure of human fibroblast growth factor receptor 1 kinase domain in complex with pyrazolaminopyrimidine 2 |
|
2
|
15
|
4ogaF |
Insulin in complex with site 1 of the human insulin receptor |
|
114
|
526
|
4o3uB |
Zymogen hgf-beta/met with zymogen activator peptide zap2.3 |
|
114
|
525
|
4o3tB |
Zymogen hgf-beta/met with zymogen activator peptide zap.14 |
|
87
|
302
|
4nk9A |
Crystal structure of human fibroblast growth factor receptor 1 kinase domain in complex with pyrazolaminopyrimidine 1 |
|
84
|
309
|
4oh4A |
Crystal structure of bri1 in complex with bki1 |
|
86
|
298
|
4nksA |
Crystal structure of human fibroblast growth factor receptor 1 kinase domain in complex with pyrazolaminopyrimidine 3 |
|
98
|
295
|
4mxcA |
Crystal structure of cmet in complex with novel inhibitor |
|
90
|
516
|
4m4pA |
Crystal structure of epha4 ectodomain |
|
152
|
604
|
4leoC |
Crystal structure of anti-her3 fab rg7116 in complex with the extracellular domains of human her3 (erbb3) |
|
68
|
284
|
4mhaA |
Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase mer in complex with inhibitor unc1817 |
|
61
|
186
|
4lscA |
Isolated serk1 co-receptor ectodomain at high resolution |
|
102
|
309
|
4mkcA |
Crystal structure of anaplastic lymphoma kinase complexed with ldk378 |
|
62
|
284
|
4m3qA |
Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase mer in complex with inhibitor unc1917 |
|
71
|
321
|
4ll0A |
Egfr l858r/t790m in complex with pd168393 |
|
90
|
516
|
4m4rA |
Epha4 ectodomain complex with ephrin a5 |
|
96
|
323
|
4lqmA |
Egfr l858r in complex with pd168393 |
|
68
|
285
|
4mh7A |
Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase mer in complex with inhibitor unc1896 |
|
72
|
307
|
4lrmA |
Egfr d770_n771insnpg in complex with pd168393 |
|
89
|
481
|
4liqE |
Structure of the extracellular domain of human csf-1 receptor in complex with the fab fragment of rg7155 |
|
91
|
328
|
4li5A |
Egfr-k in complex with n-[3-[[5-chloro-4-(1h-indol-3-yl)pyrimidin-2-yl]amino]-4-methoxy-phenyl] prop-2-enamide |
|
60
|
205
|
4krlA |
Nanobody/vhh domain 7d12 in complex with domain iii of the extracellular region of egfr, ph 6.0 |
|
113
|
609
|
4krpA |
Nanobody/vhh domain 9g8 in complex with the extracellular region of egfr |
|
35
|
199
|
4k94C |
Crystal structure of kit d4d5 fragment in complex with anti-kit antibody fab19 |
|
37
|
175
|
4l0pA |
Structure of the human epha3 receptor ligand binding domain complexed with ephrin-a5 |
|
58
|
197
|
4krmA |
Nanobody/vhh domain 7d12 in complex with domain iii of the extracellular region of egfr, ph 3.5 |
